Technology & AI

Google DeepMind unveils AI model predicting genetic variant effects on cells

The tool is a new version of DeepMind's AlphaGenome system, and it is aimed at research use rather than public release.

By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .

This story is no longer being updated. It reflects reporting up to .

What happened

Google DeepMind has unveiled AlphaGenome 2, an AI model designed to predict how genetic variants affect specific cell types and states. It was trained on more than 100 million cell profiles across 68 tissues. Genomics Limited plans to add it to its Mystra platform, letting drugmakers estimate which genes a DNA variant affects and in which cells before deciding what to test.

Why it matters

Google says it is available for research only.

Timeline

  1. Nov 11, 12:24 PM ET: Google DeepMind unveiled AlphaGenome 2, an AI model that predicts how genetic variants affect specific cell types and states.
  2. Nov 12, 4:39 AM ET: Genomics Limited plans to add AlphaGenome 2 to its Mystra platform so drugmakers can predict which genes a DNA variant affects and in which cells.

Coverage

More on this story

More from Technology & AI

All Technology & AI news · Technology & AI story archive